Importer of Controlled Substances; Notice of Registration, 73368 [E7-25038]

Download as PDF 73368 Federal Register / Vol. 72, No. 247 / Thursday, December 27, 2007 / Notices No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cedarburg Pharmaceuticals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cedarburg Pharmaceuticals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: December 17, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–25044 Filed 12–26–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated August 16, 2007, and published in the Federal Register on August 27, 2007, (72 FR 49020), Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: mstockstill on PROD1PC66 with NOTICES Drug Schedule 4–Methoxyamphetamine (7411). Dihydromorphine (9145) Difenoxin (9168) ............. Amphetamine (1100) ...... Methamphetamine (1105) Methylphenidate (1724) .. Pentobarbital (2270) ....... Codeine (9050) ............... Dihydrocodeine (9120) ... Oxycodone (9143) .......... Hydromorphone (9150) ... Hydrocodone (9193) ....... Meperidine (9230) ........... Dextropropoxyphene, bulk (non-dosage forms) (9273). Morphine (9300) ............. VerDate Aug<31>2005 I I I II II II II II II II II II II II II 18:00 Dec 26, 2007 Jkt 214001 Drug Schedule Thebaine (9333) ............. Oxymorphone (9652) ...... Noroxymorphone (9668) Alfentanil (9737) .............. Sufentanil (9740) ............ Fentanyl (9801) ............... II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chattem Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Chattem Chemicals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: December 17, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–25040 Filed 12–26–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated CIMA Labs, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: December 18, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–25038 Filed 12–26–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated August 16, 2007, and published in the FEDERAL REGISTER on August 27, 2007, (72 FR 49021), Cody Laboratories, 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated August 28, 2007 and published in the Federal Register on September 10, 2007, (72 FR 51664), CIMA Labs, Inc., 7325 Aspen Lane, Brooklyn Park, Minnesota 55428 made application by letter to the Drug Enforcement Administration (DEA) to be registered as an importer of Nabilone (7379), a basic class of controlled substance listed in schedule II. The company plans to import the basic class of controlled substance for clinical trials and research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of CIMA Labs, Inc. to import the basic class of controlled substance is PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 Drug Dihydromorphine (9145) Amphetamine (1100) ...... Methamphetamine (1105) Amobarbital (2125) ......... Pentobarbital (2270) ....... Secobarbital (2315) ........ Phenylacetone (8501) ..... Cocaine (9041) ............... Codeine (9050) ............... Dihydrocodeine (9120) ... Oxycodone (9143) .......... Hydromorphone (9150) ... Diphenoxylate (9170) ...... Meperidine (9230) ........... Methadone (9250) .......... Oxymorphone (9652) ...... Alfentanil (9737) .............. Sufentanil (9740) ............ Fentanyl (9801) ............... Schedule I II II II II II II II II II II II II II II II II II II The company plans on manufacturing the listed controlled substances in bulk for sale to its customers. E:\FR\FM\27DEN1.SGM 27DEN1

Agencies

[Federal Register Volume 72, Number 247 (Thursday, December 27, 2007)]
[Notices]
[Page 73368]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-25038]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated August 28, 2007 and published in the Federal 
Register on September 10, 2007, (72 FR 51664), CIMA Labs, Inc., 7325 
Aspen Lane, Brooklyn Park, Minnesota 55428 made application by letter 
to the Drug Enforcement Administration (DEA) to be registered as an 
importer of Nabilone (7379), a basic class of controlled substance 
listed in schedule II.
    The company plans to import the basic class of controlled substance 
for clinical trials and research.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of CIMA Labs, Inc. to import the basic class of controlled 
substance is consistent with the public interest and with United States 
obligations under international treaties, conventions, or protocols in 
effect on May 1, 1971, at this time. DEA has investigated CIMA Labs, 
Inc. to ensure that the company's registration is consistent with the 
public interest. The investigation has included inspection and testing 
of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: December 18, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-25038 Filed 12-26-07; 8:45 am]
BILLING CODE 4410-09-P